Ignite Creation Date:
2025-12-24 @ 12:24 PM
Ignite Modification Date:
2025-12-28 @ 11:54 AM
Study NCT ID:
NCT03833661
Status:
COMPLETED
Last Update Posted:
2023-10-25
First Post:
2019-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)
Sponsor:
EMD Serono Research & Development Institute, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MS200647_0047
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |